Xiaoxiang H. Peng

Weifang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Reverse Regulation of Th1 and Treg Immune Responses by P2X7 Receptor: A Possible Cause of the Progression of Experimental Autoimmune Uveitis.

Reverse Regulation of Th1 and Treg Immune Responses by P2X7 Receptor: A Possible Cause of the Progression of Experimental Autoimmune Uveitis.

Journal: Current eye research

Published: September 02, 2025

The P2X7 receptor in leukemia: pathological mechanisms and therapeutic potential.

The P2X7 receptor in leukemia: pathological mechanisms and therapeutic potential.

Journal: Purinergic signalling

Published: April 26, 2025

Blocking or knockdown of P2X7 receptor inhibits invasion and migration of mouse breast cancer cells via PI3K/Akt/GSK-3β pathways and EMT.

Blocking or knockdown of P2X7 receptor inhibits invasion and migration of mouse breast cancer cells via PI3K/Akt/GSK-3β pathways and EMT.

Journal: Medical oncology (Northwood, London, England)

Published: April 19, 2025

P2X7R: A Critical Regulator and Potential Therapeutic Target for Glioma.

P2X7R: A Critical Regulator and Potential Therapeutic Target for Glioma.

Journal: Journal of neuroscience research

Published: February 06, 2025

Overexpression or knockdown of the P2X7 receptor regulates the progression of non-small cell lung cancer, involving GSK-3β and JNK signaling pathways.

Overexpression or knockdown of the P2X7 receptor regulates the progression of non-small cell lung cancer, involving GSK-3β and JNK signaling pathways.

Journal: European journal of pharmacology

Published: October 11, 2024

The Purinergic Ligand-Gated Ion Channel 7 Receptor Promotes the Proliferation, Invasion, and Migration of Breast Cancer Cells.

The Purinergic Ligand-Gated Ion Channel 7 Receptor Promotes the Proliferation, Invasion, and Migration of Breast Cancer Cells.

Journal: Journal of biochemical and molecular toxicology

Published: July 23, 2024

Role and Therapeutic Potential of P2X7 Receptor in Lung Cancer Progression.

Role and Therapeutic Potential of P2X7 Receptor in Lung Cancer Progression.

Journal: Current medicinal chemistry

Published: June 12, 2024

Role of the P2X7 receptor in breast cancer progression.

Role of the P2X7 receptor in breast cancer progression.

Journal: Purinergic signalling

Published: March 23, 2024

The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers.

The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: November 09, 2023

Phasic regulation of the ATP/P2X7 receptor signaling pathway affects the function of antigen-presenting cells in experimental autoimmune uveitis.

Phasic regulation of the ATP/P2X7 receptor signaling pathway affects the function of antigen-presenting cells in experimental autoimmune uveitis.

Journal: International immunopharmacology

Published: January 12, 2023

Purinergic P2X7R as a potential target for pancreatic cancer.

Purinergic P2X7R as a potential target for pancreatic cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 21, 2022

P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways.

P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways.

Journal: Purinergic signalling

Published: November 29, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026